CAR-T cell therapy is a type of treatment for certain blood cancers that involves modifying a patient's T-cells in a lab by adding a gene for a chimeric antigen receptor (CAR). This enables the modified T-cells to attach to a specific cancer cell antigen and work to eliminate the cancer. CAR-T cell therapy is typically used after other cancer treatments have failed and may require multiple modified T-cells.
Biopharma: The CAR-T Party is Getting Crowded
28 July 2022